Gesynta Pharma

Gesynta

This pharmaceutical company develops non-hormonal oral treatments targeting chronic inflammation and pain for patients with endometriosis and other inflammatory conditions.

ForEndo Pharma

The company develops hormone regulation therapies for women with endometriosis and polycystic ovary syndrome.

Oriva

This clinical-stage biotechnology company develops therapies for chronic gynecological diseases, including endometriosis and uterine fibroids, for women requiring non-hormonal or disease-modifying treatment options.

Afynia

This company develops non-invasive blood tests to diagnose endometriosis for women and fertility clinics.

Endometrics

Endometrics develops non-invasive diagnostic tests using menstrual blood samples and genomic biomarkers to detect endometriosis for women and healthcare providers.

Lumavita AG

This pharmaceutical company develops and commercialises anti-infective drugs for women's health, specifically targeting gynecological infections for patients globally.

Metri

This biotechnology company develops organoid-based human models to create therapeutics for patients with uterine and endometrial diseases.

Samphire Neuroscience

This company develops a neurostimulation headband providing non-invasive brain stimulation to manage menstrual pain and mood symptoms for women and individuals with periods.